Concepedia
Statistics
Publications
20
Citations
759
H-Index
13
Active since
2000
Affiliations
Noxxon Pharma (Germany)(Current)
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
Bayer (Germany)
Freie Universität Berlin
Sapienza University of Rome
Kai Riecke is an author at Noxxon Pharma (Germany) specializing in medicine, pharmacology, and immunology.
Publications per year
2000–2024
Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans
Lucas T. van Eijk, Aaron S. E. John, Frank Schwoebel et al. · Blood · 2014 · 109 citations · Full text
Veterinary Medicine, Immunology, Nutritional Sciences +16
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia
Michael Steurer, Marco Montillo, Lydia Scarfò et al. · Haematologica · 2019 · 91 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +17
Safety, pharmacokinetics and pharmacodynamics of the anti‐hepcidin Spiegelmer lexaptepid pegol in healthy subjects
Malcolm Boyce, Steve Warrington, B Cortezi et al. · British Journal of Pharmacology · 2016 · 81 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +13
Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib–dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study
Heinz Ludwig, Katja Weisel, Maria Teresa Petrucci et al. · Leukemia · 2017 · 81 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay
G. Ehling, Monica Hecht, A. Heusener et al. · Toxicology · 2005 · 65 citations
Medicine, Immunology, Immunopathology +8
1–5 of 20